Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

NCT00003603 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

660

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: idarubicin
DRUG: lomustine
DRUG: melphalan
DRUG: prednisolone

Sponsor

Riverside Haematology Group